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The increasing prevalence of gastroesophageal reﬂux disease (GERD) in children and adults, and of “silent reﬂuxers” in particular,
increases the responsibility of dentists to be alert to this potentially severe condition when observing unexplained instances of
tooth erosion. Although gastroesophageal reﬂux is a normal physiologic occurrence, excessive gastric and duodenal regurgitation
combined with a decrease in normal protective mechanisms, including an adequate production of saliva, may result in many
esophageal and extraesophageal adverse conditions. Sleep-related GERD is particularly insidious as the supine position enhances
the proximal migration of gastric contents, and normal saliva production is much reduced. Gastric acid will displace saliva easily
from tooth surfaces, and proteolytic pepsin will remove protective dental pellicle. Though increasing evidence of associations
between GERD and tooth erosion has been shown in both animal and human studies, relatively few clinical studies have been
carried out under controlled trial conditions. Suspicion of an endogenous source of acid being associated with observed tooth
erosion requires medical referral and management of the patient as the primary method for its prevention and control.
1.Introduction
Both endogenous (intrinsic) acid and exogenous (extrinsic)
sources of acids are responsible for the increasing incidence
and high prevalence of tooth erosion and associated tooth
sensitivity observed in many countries, in both children and
adults [1]. Not only may the tooth erosion from endogenous
acid be more severe than that from exogenous acids but also
gastric reﬂux, regurgitation, and microaspiration may have
signiﬁcant adverse eﬀects on the mucosa of the esophagus,
oropharynx, and respiratory system [2–6].
A recent systematic review found a median prevalence
of 24% for tooth erosion in patients with gastroesophageal
reﬂux disease (GERD) and a median prevalence of 32.5%
for GERD in adult patients who had tooth erosion [7].
Therefore, from their observations of tooth erosion, dentists
may be the ﬁrst persons to diagnose the possibility of
GERD, particularly in the case of “silent reﬂuxers.” This
diagnosis is important, as GERD has increased in prevalence
in many countries, and may have severe health eﬀects if not
adequately treated [8, 9]. Consequently, dentists should be
more aware of the various manifestations of GERD in both
children and adults.
2. Gastroesophageal Reﬂux and
Antireﬂux Barriers
Gastroesophageal reﬂux (GER) is deﬁned as a normal, phys-
iologic retrograde ﬂow of gastric contents into the esophagus
that occurs mostly postprandial (after meals) for around
one hour per day [10]. A GER episode is diagnosed when
esophageal pH drops below 4.0 for at least 30 seconds [11].
But, in healthy individuals, the acidic reﬂux is cleared by
esophageal peristalsis and saliva within 1-2 minutes [12].
Saliva also helps to buﬀer (neutralize) esophageal acid [13]
and to lubricate the esophagus against mechanical damage
from a food bolus [10].
An antireﬂux barrier at the gastroesophageal junction is
formedbynormalanatomicalfeatures,includingtheoblique
course of the gastroesophageal junction and diaphragmatic
curve. Of particular importance is a high-pressure gradient
of 10–30mmHg maintained by tonic contraction of the
circular muscles of the lower esophageal sphincter (LES).
Luminal clearance of the esophagus is aided by gravity
when upright, by physiological emptying (peristalsis) of
the esophageal contents into the stomach and by salivary
bicarbonate [14, 15].2 International Journal of Dentistry
3.Pathophysiology of
Gastroesophageal Reﬂux Disease
GERdoesnotproducegastricsymptomsormucosaldamage,
but can progress into a clinical disorder termed gastroe-
sophageal reﬂux disease (GERD), usually characterized by
symptoms of heartburn and acid regurgitation [16]. A global
deﬁnition and classiﬁcation of GERD has been developed
by the Montreal consensus group, based on voting by 44
physicians from 18 countries on several evidence-based
statements on the characteristics of GERD. [17]. GERD
has been deﬁned as “a condition that develops when the
reﬂux of stomach contents causes troublesome symptoms
and/or complications,”and its manifestations havebeen sub-
classiﬁed into esophageal and extraesophageal syndromes
[17] .R e c e n t l y ,a t t e m p t sh a v eb e e nm a d et od e ﬁ n eG E R D
speciﬁcally for the pediatric population (including infants,
children, and adolescents) in light of observations of a wider
range of variability in the signs and symptoms in children
compared with adults [18].
GERD can occur both during sleep (nocturnal) and
waking (day time) stages, and 40–81% of individuals who
reported symptoms of GERD also experienced symptoms
during sleep [19–23]. Sleep-related GERD occurs more
frequently during the lighter nonrapid eye movement (non-
REM) sleep, particularly during the ﬁrst two hours of
sleep, than during the REM stage [12, 24]. These episodes
also occur less frequently, but last for longer periods, than
those during the waking stage [25]. Each sleep-related
GERD episode has been noted to typically last for 15–20
minutes compared with 1-2 minutes during the waking
stage [12]. These episodes can recur continuously to lower
the esophageal pH below 4.0 for a period of around 60
minutes, including a period of 10 minutes when esophageal
pH stays at 1.0, until the pH gradually recovers to above 4.0
(Figure 1)[ 26]. This situation demonstrates the potential for
erosive damage to both the esophageal and extraesophageal
structures during sleep-related GERD.
The body has several mechanisms to protect the esoph-
agus against the eﬀects of acid reﬂux during the waking
period. Acid contact on the mucosa in the distal esophagus
(near the gastroesophageal junction) during the waking state
induces increased salivary ﬂow and swallowing mechanisms
(primary peristalsis), and localized esophageal peristalsis
(secondary peristalsis) to buﬀer the acid and facilitate
volumetric clearance [12, 27]. These antireﬂux protective
mechanisms also occur during sleep, but at a diminished
level. Salivary ﬂow is greatly reduced during sleep, but saliva
secreted intermittently in response to orofacial movements,
such as chewing-like jaw activity or rhythmic masticatory
muscle activity, helps to lubricate the esophageal mucosa
[28]. An experimental study on healthy individuals has
shown that acid infusion into the esophagus during sleep
resulted in a brief period of arousal with a swallowing
reﬂex, which was also believed to promote saliva ﬂow [29].
Therefore, sleep-related acid reﬂux may induce similar
responses, as well as the perception of heartburn, which are
known to be important mechanisms responsible for salivary
secretion, volumetric clearance of the reﬂuxate, and the
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Figure 1: Pattern of sleep-related esophageal acid exposure in
a patient with erosive esophagitis. Night-time acid reﬂux during
supinesleepleadstopHlevels<4thatarecontinuousandsustained.
(Reproduced Figure 2, page 111S, from Orr [26]. With copyright
permission from Elsevier).
prevention of pulmonary aspiration [30]. Even though these
antireﬂux mechanisms operate in the majority of GERD
patients during sleep, there is still a greater risk of proximal
m i g r a t i o no fr e ﬂ u x a t ea sw e l la sa ni n c r e a s e dd u r a t i o no f
acid-mucosa contact during sleep compared with the waking
state [12, 31]. Thus, sleep-related GERD poses a greater risk
of developing esophageal complications (including reﬂux
esophagitis) and extraesophageal complications (including
respiratory tract conditions and pulmonary microaspiration
of the reﬂuxate) compared with the waking state [23, 26,
31]. In essence, GERD disturbs sleep and sleep disturbances
worsen GERD [32, 33].
4. Risk Factors for GERD
GERD is usually caused by a transient relaxation of the
LES and less commonly by a transient increase in intra-
abdominal pressure or a low resting pressure of the LES
[34]. Generally recognized risk factors for gastric regur-
gitation include conditions that cause LES incompetence
(alcohol, nicotine, caﬀeine, many medications, and hiatal
hernia), conditions that cause increased intra-abdominal
pressure (obesity, pregnancy, straining, and bending), and
conditions that cause increased gastric volume (heavy meals
and intestinal obstruction). Alcohol consumption may also
increase gastric acid secretion and delay gastric emptying,
and nonsteroidal anti-inﬂammatory drugs may interfere
with prostaglandin cytoprotection [35]. Obstructive sleep
apnoea (OSA) and obesity predispose to nocturnal GERD,
with more than 100 reﬂux episodes reported during an 8-
hour sleep in individuals suﬀering from OSA [36, 37]. The
consumption of spicy and acidic foods and beverages may
also aggravate GERD problems.
5.DiagnosisofGERD
Common methods for the diagnosis of GERD include the
assessment of gastric symptoms, a proton pump inhibitor
(PPI) drug test, esophageal pH monitoring, and upper endo-
scopy [8].International Journal of Dentistry 3
As both gastric and duodenal reﬂux occur frequently in
individuals suﬀering from GERD, a combined assessment is
important in obtaining a holistic understanding of its patho-
physiology [38]. Esophageal symptoms can be associated
with either acid or bile or a combination of both in GERD
patients, but the majority of symptoms are associated with
gastric acid [39]. Furthermore, duodenal reﬂuxate in the ab-
sence of gastric reﬂuxate does not cause reﬂux esophagitis
[40].
Classicalsymptoms ofGERDinadultsareheartburnand
acid regurgitation causing a sour taste, with less common
symptoms being dysphagia (diﬃculty swallowing), water
brash (ﬂooding of the mouth with saliva), odynophagia
(pain on swallowing), burping/belching, chronic cough/
hoarse voice, nausea, and vomiting [41]. However, cultural
diﬀerences and language barriers need to be considered in
diagnosing GERD because of the diﬃculties associated with
direct translation of English words (such as heartburn) into
other languages [8]. Also, it is obvious that an assessment of
symptoms alone will be unable to detect instances of “silent
GERD.”
It is generally agreed that the overall management of
GERD should focus on reducing acid regurgitation with
the use of PPIs initially, and antireﬂux surgery if required
subsequently [40]. In the absence of serious symptoms and
signs, PPIs administered over 1–4 weeks are a cost-eﬀective
initial treatment therapy and diagnostic test for GERD [42].
If regurgitation symptoms fail to respond to this treatment,
patients are usually followed up with pH-monitoring studies
[8, 43].
pH monitoring is considered to have the highest sensi-
tivity (ability to detect true cases as positive) and speciﬁcity
(ability to diagnose false cases as negative) in diagnosing
GERD [44]. pH-monitoring systems include a 24-hour
catheter-based pH-monitoring system and a 48-hour wire-
less pH-monitoring system. The latter system causes less
interference in daily life activities and has higher sensitivity
and speciﬁcity than the former [43, 45, 46].
Assessment of symptoms and pH monitoring are not re-
liablefordetectingerosivechangesintheesophagealmucosa.
Reﬂux esophagitis, referring to the injury with inﬂammation
of the esophagus from gastric reﬂuxate, is a common mani-
festation of GERD that is recognized during endoscopy [16].
However, in one study, most patients showed only mild or
no erosion of the esophageal mucosa [47]. Endoscopy is also
used to detect Barrett’s esophagus and hiatal hernia and for
sampling for the presence of Helicobacter pylori from gastric
mucosa [46, 48].
6.AdvancedEsophageal
Manifestationsof GERD
S e v e r ef o r m so fG E R Dh a v eb e e na s s o c i a t e dw i t hB a r r e t t ’ s
esophagus, which is a form of esophageal metaplasia charac-
terized by aneuploidy (abnormal number of chromosomes)
[2]. This condition can progress to low-grade and high-
grade dysplasia and is the strongest risk factor for esophageal
adenocarcinoma [2, 49]. As the second most common form
of esophageal neoplasm after squamous cell carcinoma,
esophageal adenocarcinoma has a very poor long-term out-
come with a high mortality [3, 50].
Fortunately, several very large longitudinal studies sug-
gest that only a minority of GERD suﬀerers develop Barrett’s
esophagus [51, 52]. These studies found that Barrett’s
esophagus developed in 0.0–1.8% of persons with nonero-
sive esophagitis and in 1.0–9.9% of persons with erosive
esophagitis.Thus,theoverallriskofdevelopmentofBarrett’s
esophagus in GERD suﬀerers is low, though generally
increasing, with a slightly elevated risk in individuals with
erosive esophagitis.
A very low incidence of 1.0 per 100,000 for esophageal
adenocarcinoma was reported in male American White and
non-Hispanic GERD suﬀers aged below 50 years, which
increased for older men to reach an incidence of 60.8 per
100,000in70-yearolds[53].Theriskinwomenwasverylow
acrossallagegroups,increasingto3.9per100,000at60years.
Based on these ﬁndings, recommendations for endoscopic
examinations for adenocarcinoma were not advised in men
aged less than 50 years and in women of all age groups,
regardless of GERD symptoms [54].
However, a recent systematic review and meta-analysis
of population-based studies found associations between
frequent GERD symptoms and esophageal adenocarcinoma,
with weekly and daily symptoms increasing the odds ratio of
esophageal carcinoma by ﬁvefold and sevenfold, respectively
[3]. In a population-based case-control study investigating
the association between obesity, GERD, and esophageal
adenocarcinoma in White Australians, a greater risk of
progression of adenocarcinoma was observed in men than
in women [55]. The relative risk of adenocarcinoma was
alarmingly higher in obese individuals who experienced fre-
quentGERDsymptomsthaninobesepersonswithnoGERD
symptoms. Pooled data on esophageal adenocarcinoma and
cigarette smoking showed that smoking also increased the
risk of esophageal adenocarcinoma [56]. However, a recent
reviewreportedinconsistentassociationsbetweendiets(con-
taining meat and high-fat levels) and esophageal changes
(including Barrett’s esophagus, esophageal adenocarcinoma,
and esophagogastric junction adenocarcinoma) [57]. These
ﬁndings provide some information about possible risk
factors for Barrett’s esophagus and adenocarcinoma, but
caution is needed when interpreting the results because of
the lack of control over GERD, as a confounding variable. In
this context, further research is needed to clarify the roles of
lifestyle factors and their interaction with GERD in causing
Barrett’s esophagus and esophageal adenocarcinoma.
7. Extraesophageal Manifestationsof GERD
Extraesophageal manifestations possibly resulting from
GERD include laryngeal (reﬂux laryngitis, hoarseness,
chroniccough,vocalcordulcer,andgranuloma),pharyngeal
(mucositis), respiratory (asthma, bronchitis, chronic cough,
and aspiration pneumonia), sinus (sinusitis), middle ear
(otitis media), and oral conditions (tooth erosion and
sensitivity, sour taste, halitosis, and mucositis) [4, 6, 58, 59].
Oral manifestations of gastric conditions have been largely
ignored in the gastroenterology literature, though a recent4 International Journal of Dentistry
gastroenterology textbook very brieﬂy included in an
attempt this topic to provide a holistic approach for the
management of several gastrointestinal conditions [41].
Oral mucosal lesions may result from GERD by direct
acid or acidic vapor contact in the oral cavity [41]. However,
there is a paucity of information on the eﬀect of GERD on
oral mucosal changes. One large case-control study observed
a signiﬁcant association of GERD with erythema of the
palatal mucosa and uvula [60]. A histologic examination
of palatal mucosa found a greater prevalence of epithelial
atrophy, deepening of epithelial crests in connective tissue,
and a higher prevalence of ﬁbroblasts in 31 GERD patients
compared with 14 control subjects [61]. But these changes
were not visible to the naked eye, and the risk of any
progression to carcinoma was not known. Though this same
study of persons with and without GERD reported a lack
of signiﬁcant diﬀerences in salivary ﬂow rates, buﬀering
capacity, and pH values [61], the more recent large case-
control study found a signiﬁcant association between GERD
and xerostomia [60].
8. Interactionbetween
Endogenous Acid andSaliva
Althoughthefunctionsofsalivaaretoomanytodetailinthis
paper,itiswellestablishedthatsalivaplaysamajorprotective
role in the oral cavity [62]. Apart from providing all the raw
ingredients necessary for the repair of hard tooth tissue by
remineralization [63], the buﬀering action of saliva in both
the resting and particularly in the stimulated states is one of
its most important attributes [62]. These two functions are
enhanced by saliva’s antibacterial and antifungal properties
thatinherentlycontrolthenatureoftheoralbioﬁlmactingas
aprotectiveentity.Itcanbearguedthattheseandmanyother
functionsareevidenceofa“balanced”symbioticrelationship
existing between the host and the oral bioﬁlm. A breakdown
of this balance often leads to disease.
The functions outlined are often used as evidence for the
protective role of saliva against endogenous and exogenous
acids. Although this protective role appears logical, it can be
argued that saliva has little protective ability in severe erosive
conditions. Endogenous acid has a pH of approximately 1.2,
which is well below the critical pH for dissolution of hydrox-
yapatite and ﬂuorapatite [64, 65]. And the acid often acts on
toothstructureinsituationswherethesalivaiscompromised
both in quality and quantity. Even if the saliva is not
compromised, such low pH acidic environments cause rapid
demineralization of tooth surfaces for a number of reasons.
The dynamic interaction between diﬀerent ﬂuids such as
various acids and saliva is determined by several factors, the
most important being the surface tension of each ﬂuid and
the contact angles that each advancing ﬂuid front forms with
the tooth surface (Figure 2). As a general rule, acids will dis-
place saliva easily, while saliva will not readily displace acids
[66]. There is a strong case that the presence of saliva has no
direct beneﬁt or protection against endogenous acid erosion,
which may occur initially when only resting saliva is present.
In addition, the surfaces of the teeth during active
endogenous acid erosion are largely devoid of protective
bioﬁlm and stains due to gastric acid, and also possible
proteolytic pepsin. This is an “open system” where the raw
products resulting from hard tooth tissue demineralization
are lost and are not available to be reused when the oral pH
increases back to normal levels [67]. The chemical action
causes rapid dissolution of exposed tooth surfaces that is
distinctly diﬀerent from the subsurface dissolution seen with
plaque acids [68]. Under magniﬁcation, the eroded tooth
surfaces will show damage to the ends of the enamel rods,
which will only remineralize after the endogenous acid has
been cleared from the oral cavity and after salivary pellicle
has been reestablished on the tooth surfaces.
The addition of remineralizing ions to the eroded
surfaces will only result in the repair of the ends of the
enamel rods as the “gross” surface damage is irreversible.
Even when ﬂuorapatite is present in high concentrations, the
remineralized surfaces provide little or no extra protection
to further sustained demineralization as the endogenous
acid has a pH well below 4.5, which is the approximate
critical pH for ﬂuorapatite dissolution [69]. These ﬁndings
are supported by observations that ﬂuoride-based and
casein-based (amorphous calcium phosphate stabilized by
casein-phosphopeptide) remineralizing agents provide some
protection against erosion at pH 3.0 [70–73], but not at a
highly erosive environment of pH 1.2 [74, 75].
As a result, the principal method for preventing the
endogenous tooth erosion from occurring is to eliminate
the primary cause, requiring a close relationship with the
patient’s medical practitioner. The success of medical inter-
vention is quite variable among patients, and their treatment
is often diﬃcult to manage. From the dental practitioner’s
perspective, any possible exogenous dietary and other acids
that may be contributing to the problem also need to be
eliminated and saliva production stimulated.
In addition to attempting to eliminate the primary cause,
the placement of any physical barrier between the tooth
surfaces and the endogenous acid should be of beneﬁt. Many
“metal ion” ﬂuorides such as SnF, AgF, TiF4,a n dF e F 3 have
been tested and do show some laboratory evidence of a
protective eﬀect [76]. The mechanism of action is probably
not by the ﬂuoride ion itself, but by the metal ion precipitate
that forms a physical barrier to the acid. Other dental
products that can be used as, often, temporary physical
barriers to acid include resin-based viscous varnishes,
resin-based dentin bonding agents [77], and a thin layer
of an unﬁlled/lightly ﬁlled clear adhesive resin sealant or
glass-ionomer cement [78]. Alternatively, casein-based
remineralizing paste acts as an artiﬁcial bioﬁlm that contains
all the raw products for tooth tissue remineralization [79].
However, surface barrier products generally require testing
in independent controlled trials to identify their eﬃcacy and
long-term clinical cost eﬀectiveness.
9.Associationbetween
Tooth Erosion andGERD
Dental erosion or, more correctly, corrosion is described
as tooth surface loss produced by chemical or electrolytic
processes of nonbacterial origin, which usually involvesInternational Journal of Dentistry 5
Enamel rods HA: Ca10(PO4)6(OH)2
Erosion
Acid
Ca++
Advancing front The surface tension of the acid is less than saliva
thereby wetting the tooth surface more readily
Saliva Demineralization
“Dished out lesion”
(1) Repeated acid attack removes pellicle protection allowing acid to contact the tooth surface
(2) Acid easily displaces saliva (has lower surface tension and hence contact angle)
(3) An “open system,”therefore the demineralization products are lost
(4) The acid causes “rampant” demineralization of the tooth surface producing a
dished out appearance
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Figure 2: When dental pellicle is removed by sustained endogenous acid attacks, then demineralized tooth products are lost to the oral
environment. HA: hydroxyapatite. (Amended Figure 2.5, page 15, from Smales et al. [67]. With copyright permission from Jaypee Medical
Publishers 2011.)
acids [80]. The acids are of endogenous (intrinsic) origin
from reﬂuxed gastric juices (Figure 3) and/or of exogenous
(extrinsic) origin from usually dietary, medicinal, occupa-
tional, and recreational sources. The erosive potential of the
acids is modiﬁed by many secondary factors.
As part of what is known as the Montreal consensus,
44 physicians from 18 countries voted on the statement
that “The prevalence of dental erosions, especially on the
lingual and palatal tooth surfaces, is increased in patients
with GERD” [17]. Although the result was a high-grade
consensus agreement of 96%, only 42% of the votes “agreed
strongly” with the statement, 35% “agreed with minor
reservations,” and 19% “agreed with major reservations.”
Only three selected clinical studies quoted to support
the statement [81–83]. The global consensus report also
stated that extraesophageal syndromes rarely occurred in
isolation without concomitant manifestations of the typical
esophageal syndrome, that these association syndromes are
usually multifactorial with GERD as one of several poten-
tial aggravating cofactors, and that data substantiating a
beneﬁcial eﬀect of reﬂux treatments on the extraesophageal
syndromes are weak [17].
Subsequently, eight pediatric gastroenterologists using
a revision of the original Montreal protocol voted on the
statementthat“GERDmaycausedentalerosionsinpediatric
patients” [18] .T h er e s u l tw a sal o w - g r a d ec o n s e n s u sa g r e e -
ment of 100%, with just 12.5% of the votes “agreed strongly,”
37.5% “agreed moderately,” and 50% “just agreed.” One
systematic review article [7] and four other selected clinical
articles [84–87] were quoted to support the statement. Den-
tal erosion was only one of two extraesophageal syndromes
consideredtobedeﬁnitelyassociatedwithGERDinpediatric
patients, the other being Sandifer’s syndrome (torticollis)
[18]. Asthma and laryngopharyngeal syndromes were not
consideredtobedeﬁnitelyassociatedwithGERDinchildren,
unlike their established associations in adults [17]. The
reporting of symptoms caused by GERD is likely to be unre-
liable in children under the age of approximately eight years
and in older persons lacking suﬃcient cognitive abilities.
Tooth erosion associated with GERD was apparently ﬁrst
reported in 1933 [88]. However, apart from the subsequent
occasional publications of case reports, until the 1990s few
research publications evaluated this association. Several of
these later research studies were discussed by Bartlett [4]
and by Wong et al. [8] who concluded, respectively, that
therewasaclearthoughvariablerelationshipbetweenGERD
and dental erosion and that controlled clinical studies were
required to show that the progression of dental erosion
ceased after adequate gastric acid suppression therapy in
patients with GERD.
A recent systematic review involving 17 eligible mainly
observational and case-control studies of GERD and dental
erosion found a strong association between the two condi-
tions [7]. The median prevalence of dental erosion in GERD
patients was 24%, and the median prevalence of GERD
in adults and in children with dental erosions was 32.5%
and 17%, respectively. However, there were wide percentage
ranges and degrees of tooth tissue loss present among
the study populations, and not all studies and evaluations
of patients employed esophageal endoscopy and/or 24-h
esophageal pH-metry. One other recent systemic review
also found a higher prevalence of dental erosion, asthma,6 International Journal of Dentistry
(a) (b)
Figure 3: Frontal and maxillary occlusal views of severe tooth erosion caused by endogenous acid in a patient with GERD. (Courtesy of Dr.
A. Dickson.)
pneumonia, and sinusitis in children with GERD compared
with healthy controls [5]. The authors could not ﬁnd any
eligible studies in children with GERD that investigated
associations with bronchitis, cough, laryngitis, pharyngitis,
and sleep apnea.
A recent study of 249 referred children and adult
Icelandic persons, of whom 91 had molar erosion and/or
symptoms of gastric reﬂux and had undergone gastroscopy,
esophageal manometry, and 24-h esophageal pH-metry,
found a signiﬁcant association between diagnosed GERD
and dental erosion [48]. The severity of dental erosion in
the incisor and the molar teeth was assessed separately using
modiﬁed criteria from an erosion index [89]. Step-wise
logistic regression analyses showed signiﬁcant associations
in particular between diagnosed regurgitation and palatal
erosion, the daily consumption of more than 0.5L of
acidic drinks, and a low buﬀer capacity of saliva. However,
combining all of the factors measured in the study only
provided a low explanatory value of 15.1% for the variability
in erosion scores.
Bycontrast,alargecase-controlstudyofmenandwomen
aged from 19 to 78 years found no signiﬁcant associations
between GERD and either dental erosion or tooth sensitivity,
but signiﬁcant associations between GERD and xerostomia,
oral acid/burning sensation, subjective halitosis, and ery-
thema of the palatal mucosa and uvula [60]. GERD was
diagnosed in all new patients seen at the Gastroenterology
Department using esophagogastroduodenoscopy and 24-h
esophageal pH-metry. And dental erosion was evaluated
using a Tooth Wear Index [90], which is not restricted to
assessing tooth tissue loss from erosion alone. However,
only 9% of the 200 patients with GERD and 13% of
the 100 healthy matched controls showed evidence of any
dental erosion (tooth tissue loss). Both groups of subjects
had similar tooth sensitivities of 32.5% and 32%. It was
postulated that a signiﬁcant portion of cases (with dental
erosion) reported in the literature could have consisted of
patients with a particularly abundant reﬂux or who were
unresponsive to pharmacological therapy [60].
The ﬁrst randomized clinical trial to demonstrate quan-
titatively the short-term suppression of active tooth erosion
following the treatment of medically conﬁrmed GERD with
a proton pump inhibitor (PPI) has recently been published
[91]. Subjects with other causes for dental erosion, and who
failed to meet additional selection criteria, were excluded
from the study. Optical coherence tomography was used to
quantify the extent of enamel demineralization at multiple
speciﬁc sites in speciﬁc visibly eroded teeth both before and
after three weeks of esomeprazole therapy. In this double-
blinded study, there was signiﬁcantly less enamel thickness
lost in the 14 available adult subjects taking esomeprazole
(mean = 7.20µm) than in the 15 adult subjects taking a
placebo (mean = 15.25µm). Evidence of a mild reminer-
alization of eroded teeth in the esomeprazole subjects was
shown by a decreased optical reﬂectance at a depth of 25µm.
BecausenocturnalacidcontrolmaybeinadequatewithPPIs,
some erosion from GERD may have continued during sleep.
Most of the patients had mildly symptomatic GERD, as they
presented with a primary complaint of dental erosion.
Studies that attempt to associate tooth erosion with the
ﬁndings from esophageal pH-metry often only assess gastric
reﬂux occurring classically 5cm above the LES. However,
the reﬂuxate will only enter the oropharynx once the upper
esophageal sphincter (UES) has been breached. A signiﬁcant
correlation of palatal tooth erosion with acid reﬂux was
demonstrated in a study of 31 adult patients that employed
24-h esophageal pH-metry with dual electrodes located 5cm
above the LES and 2cm above the UES [92]. There were
signiﬁcant correlations between the proportion of the total
time (and also of the supine time) that pharyngeal pH was
below 5.5, and the proportion of teeth with obvious palatal
wear scores. (The critical pH for enamel demineralization
is approximately 5.5.) The authors concluded that the pH
(below 4.0) criterion accepted for the diagnosis of GERD at
5cmabovetheLESwasprobablynotrelevanttothepharynx.
Using male Wistar rats, an animal model was developed
to determine the eﬀects of forced and continuously occur-
ring gastroduodenal reﬂux, following esophagojejunostomy
without gastrectomy, on tooth erosion [93]. After 30 weeks,
the pH of the gastric contents in the forced reﬂux and sham-
operated control rats was 3.70 and 3.36, respectively. At this
timethepHoftheesophagealcontentsinthesacriﬁcedreﬂux
rats was 6.93 and was associated with extensive tooth erosion
in the molar teeth. (Almost no tooth erosion was observed
in the sham-operated rats.) The reﬂuxate was a mixture
of saliva, gastric, and duodenal contents that includedInternational Journal of Dentistry 7
bile secretions and probably also acidic vapor. In humans,
high intraesophageal reﬂuxates have been shown to contain
a mixed liquid-gas composition and to be signiﬁcantly
associated with GERD symptoms irrespective of an LES
recorded pH above or below 4.0 [94]. Endogenous tooth
erosion in the absence of GERD symptoms (silent reﬂuxers)
could be caused by acidic droplets/vapors and gases.
Whencomparedwithacontrolgroupofhealthysubjects,
an increased prevalence of tooth erosions was signiﬁcantly
associated with an increased frequency of respiratory symp-
toms in a recent clinical study of 88 carefully selected adult
patients with medically conﬁrmed GERD [95]. Palatal ero-
sion of maxillary incisors was found in 80% of patients with
frequentrespiratorysymptomssuchaschroniccough,laryn-
gitis, and asthma. Strong associations have been reported
between GERD and asthma [17] and between asthma and
tooth erosion [96]. Some of these associations are linked
to the systemic eﬀects of ingested and inhaled drugs in
decreasing the saliva ﬂow and LES tonus and to the acidic
nature of powdered topical drugs contained in puﬀers that
are used to treat asthma.
10. Conclusions
GERD is an increasingly common and potentially seri-
ous condition, with various extraesophageal adverse health
eﬀectsthatdentalpractitionersshouldbeawareof.Clinicians
should also be aware of the predisposing risk factors for
GERD and its classical esophageal and extraesophageal
symptoms and signs. However, not all aﬀected persons will
have the classical symptoms of gastric regurgitation. Dentists
may be the ﬁrst persons to diagnose the possibility of GERD
in these “silent reﬂuxers,” particularly when observing unex-
plained instances of tooth erosion, which might be accom-
panied by coexisting hyposalivation. Numerous laboratory,
and mainly case-control and observational clinical studies in
adults and children, have shown a clear though variable rela-
tionshipbetweenGERDandtootherosion.However,further
randomized clinical trials are required to demonstrate that
the progression of dental erosion reduces or ceases following
gastric acid suppression therapy in patients with conﬁrmed
GERD. Collaborative medical and dental management of
patients with GERD is strongly advocated.
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